Synta Pharmaceuticals (SNTA)
Synta Pharmaceuticals Market Cap: 294.49M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SNTA Market Cap Rankings
| Overall | 39th percentile | 2811 of 4665 |
| Sector | 52nd percentile | 250 of 527 in Healthcare |
| Industry | 63rd percentile | 7 of 19 in Diagnostic Substances |
SNTA Market Cap Range, Past 5 Years
| Minimum | 72.59M | Mar 2009 |
| Maximum | 294.49M | Jun 1 2012 |
| Average | 200.90M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these SNTA related companies
SNTA News
Added $SNTA calls in anticipation of favorable study results to be released this month. Buying on the rumor and selling on the news.
about 5 hours ago by theBRA1N
about 5 hours ago by theBRA1N
$SNTA Mentioned more than normal on StockTwits - Currently at 4 x average daily social activity
about 6 hours ago by TradeIdeasQuant
about 6 hours ago by TradeIdeasQuant
$snta took out key 5.00 level next stop 5.1 if htat breaks coudl get some real heat
about 9 hours ago by kunal00
about 9 hours ago by kunal00
$FB http://stks.co/43dY $FB $END $BONT $CIEN $SNTA Full blog and analysis here http://stks.co/43dZ
about 23 hours ago by LincolnList
about 23 hours ago by LincolnList
Unusual 11 Mid-Day Movers 05/31: (TLB) (CFK) (NEBS) Higher; (CHTP) (HMPR) (SMI) Lower
May 31, 1:07PM Street Insider
May 31, 1:07PM Street Insider
$snta gearing up for a run here. 4.9 level key.. looks like it could be a runner http://stks.co/43Gj
about a day ago by kunal00
about a day ago by kunal00
Gaylord Entertainment Company, Ciena Corporation Among Stocks Up on High Volume Thursday
May 31, 12:33PM Fox Business
May 31, 12:33PM Fox Business
Morning Movers 05/31: (TLB) (CFK) (NEBS) (BONT) Higher; (CHTP) (AONE) (NCIT) (NBG) Lower
May 31, 11:09AM Street Insider
May 31, 11:09AM Street Insider
$SNTA 200 Day SMA Cross - Price crossed above 200 day SMA (4.1888). Confirmed by volume.
about 7 days ago by TradeIdeasQuant
about 7 days ago by TradeIdeasQuant
Loving my $SNTA & $TQNT shorts today. Looking to cover tomorrow if all goes according to plan.
about 15 days ago by pennyinvestor29
about 15 days ago by pennyinvestor29
Synta Announces Presentations at the 2012 American Society for Clinical Oncology (ASCO) Annual Meeting
May 17, 6:30AM Business Wire
May 17, 6:30AM Business Wire
Synta to Present at the Deutsche Bank 37th Annual Health Care Conference
May 03, 1:59PM Business Wire
May 03, 1:59PM Business Wire
Synta Provides Clinical Update and Reports First Quarter 2012 Financial Results
May 03, 6:59AM Business Wire
May 03, 6:59AM Business Wire
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
Mar 27, 8:00AM Business Wire
Mar 27, 8:00AM Business Wire
Synta Announces Appointment of Dvorit Samid, Ph.D., as Vice President, Medical Affairs
Mar 12, 8:00AM Business Wire
Mar 12, 8:00AM Business Wire
Synta to Present at the Roth Capital Partners 24th Annual OC Growth Stock Conference
Mar 06, 5:03PM Business Wire
Mar 06, 5:03PM Business Wire
Synta to Present at the Cowen and Company 32nd Annual Health Care Conference
Feb 29, 4:15PM Business Wire
Feb 29, 4:15PM Business Wire
Synta Provides Clinical Update and Reports Fourth Quarter and Year End 2011 Financial Results
Feb 22, 7:43AM Business Wire
Feb 22, 7:43AM Business Wire
Synta to Host Fourth-Quarter and Year-End 2011 Conference Call on February 22, 2012
Feb 08, 7:59AM Business Wire
Feb 08, 7:59AM Business Wire
Synta Pharmaceuticals Sells Additional 1,050,000 Shares of Common Stock
Feb 06, 4:11PM Business Wire
Feb 06, 4:11PM Business Wire
Synta Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Feb 06, 8:00AM Business Wire
Feb 06, 8:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNTA | 5.11 | +0.30 | +6.24% | 277.20M |
| SNT | 0.245 | +0.01 | +6.52% | 21.13M |
| SGU | 3.93 | -0.02 | -0.51% | 242.14M |
| SGRP | 1.24 | +0.00 | +0.00% | 24.92M |
| SGOL | 160.51 | +5.92 | +3.83% | |
| SGNT | 15.98 | +0.03 | +0.19% | 444.69M |
| SGMS | 8.20 | -0.34 | -3.98% | 790.29M |
| SGMO | 4.23 | -0.21 | -4.73% | 233.37M |
| SGMA | 3.77 | -0.03 | -0.79% | 14.86M |
| SGK | 10.66 | -0.49 | -4.39% | 287.22M |